Skip to main content
Premium Trial:

Request an Annual Quote

Biotage Reports Lackluster Sales for a Disappointing Third Quarter

NEW YORK, Oct. 21 (GenomeWeb News) - Biotage today reported sales of 84.5 million Swedish krona ($11.7 million) for the third-quarter, the company said today in a statement.

 

Sales fell below company expectations because software for its upcoming purification instrument took longer to complete than planned, and deliveries were delayed, said the company. Sales were slow in the third quarter as well, but are expected to pick up in both of the company's business areas during the fourth quarter, the company added.

 

Restructurings accounted for 5 million krona of total operating costs of 73.3 million krona, but the restructurings, which reduced the number of employees by 14, will save the company 15 million krona annually, Biotage said.

 

Biotage, which  changed its name from Pyrosequencing one year ago, did not report expenses, earnings, or assets.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.